Skip to main content
. 2024 Dec 12;15:1507371. doi: 10.3389/fimmu.2024.1507371

Table 5.

Results of the multivariate analysis for relapse-free survival.

Relapse-free survival (n=395)
HR p-value 95% CI
Peritumoral TLS
None 1
Little 0.617 0.110 0.341 - 1.116
Moderate 0.663 0.161 0.373 - 1.178
Abundant 0.310 0.012 0.124 - 0.772
Pathological stage
I 1
II 2.361 0.004 1.312 - 4.251
III 8.776 <0.001 4.824 - 15.966
Adjuvant chemotherapy
No 1
Yes 0.434 <0.001 0.279 - 0.676

HR, hazard ratio; TLS, tertiary lymphoid structures.